Bases Neurobiológicas y Psicológicas de los Trastornos Mentales. Trastornos del Neurodesarrollo

Downs, JM; Lechler, S; Dean, H; Sears, N; Patel, R; Shetty, H; Simonoff, E; Hotopf, M; Ford, TJ; Diaz-Caneja, CM; Arango, C; MacCabe, JH; Hayes, RD; Pina-Camacho, L.

The Association Between Comorbid Autism Spectrum Disorders and Antipsychotic Treatment Failure in Early-Onset Psychosis: A Historical Cohort Study Using Electronic Health Records

JOURNAL OF CLINICAL PSYCHIATRY. 2017; 78(9): 1233 Nº de citas: 50 [doi:10.4088/JCP.16m11422]

Parellada, M; Pina-Camacho, L; Moreno, C; Aleman, Y; Krebs, MO; Desco, M; Merchan-Naranjo, J; Del Rey-Mejias, A; Boada, L; Llorente, C; Moreno, D; Arango, C; Janssen, J.

Insular pathology in young people with high-functioning autism and first-episode psychosis

PSYCHOLOGICAL MEDICINE. 2017; 47(14): 2472-2482 Nº de citas: 29 [doi:10.1017/S0033291717000988]

Moron-Nozaleda, MG; Diaz-Caneja, CM; Rodriguez-Toscano, E; Arango, C; Castro-Fornieles, J; de la Serna, E; Espliego, A; Sanchez-Gistau, V; Romero, S; Baeza, I; Sugranyes, G; Moreno, C; Moreno, D.

A developmental approach to dimensional expression of psychopathology in child and adolescent offspring of parents with bipolar disorder

EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2017; 26(10): 1165-1175 Nº de citas: 10 [doi:10.1007/s00787-017-0965-3]

Lim, ET; Uddin, M; De Rubeis, S; Chan, Y; Kamumbu, AS; Zhang, XC; D'Gama, AM; Kim, SN; Hill, RS; Goldberg, AP; Poultney, C; Minshew, NJ; Kushima, I; Aleksic, B; Ozaki, N; Parellada, M; Arango, C; Penzol, MJ; Carracedo, A; Kolevzon, A; Hultman, CM; Weiss, LA; Fromer, M; Chiocchetti, AG; Freitag, CM; Church, GM; Scherer, SW; Buxbaum, JD; Walsh, CA; Autism Sequencing Consortium.

Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorder

NATURE NEUROSCIENCE. 2017; 20(9): 1217 Nº de citas: 236 [doi:10.1038/nn.4598]

Haigh, SM; Matteis, MD; Coffman, BA; Murphy, TK; Butera, CD; Ward, KL; Leiter-McBeth, JR; Salisbury, DF.

Mismatch negativity to pitch pattern deviants in schizophrenia

EUROPEAN JOURNAL OF NEUROSCIENCE. 2017; 46(6): 2229-2239 Nº de citas: 16 [doi:10.1111/ejn.13660]

Hernández Del Castillo L; Martínez Bermejo A; Portellano Pérez JA; Tirado Requero P; Garriz Luis A; Velázquez Fragua R.

Rendimiento neuropsicológico en la neurofibromatosis tipo 1.

ANALES DE PEDIATRIA. 2017; 87(2): 73-77 [doi:10.1016/j.anpedi.2016.07.006]

Aleman, A; Lincoln, TM; Bruggeman, R; Melle, I; Arends, J; Arango, C; Knegtering, H.

Treatment of negative symptoms: Where do we stand, and where do we go?

Schizophrenia Research. 2017; 186: 55-62 Nº de citas: 131 [doi:10.1016/j.schres.2016.05.015]

Cenalmor-Aparicio, C; Bravo-Quelle, N; Miranda-Acuna, J; Luque-Buzo, E; Herrera-Tejedor, J; Olazaran-Rodriguez, J.

Influence of depression on the initial diagnosis and the evolution of cognitive impairment

REVISTA DE NEUROLOGIA. 2017; 65(2): 63-69 Nº de citas: 1 [doi:10.33588/rn.6502.2017088]

Canellas-Dols, F; Delgado, C; Arango-Lopez, C; Peraita-Adrados, R.

Narcolepsy-cataplexy and psychosis: a case study

REVISTA DE NEUROLOGIA. 2017; 65(2): 70-74 Nº de citas: 5 [doi:10.33588/rn.6502.2017103]

Martinez, K; Janssen, J; Pineda-Pardo, JA; Carmona, S; Roman, FJ; Aleman-Gomez, Y; Garcia-Garcia, D; Escorial, S; Quiroga, MA; Santarnecchi, E; Navas-Sanchez, FJ; Desco, M; Arango, C; Colom, R.

Individual differences in the dominance of interhemispheric connections predict cognitive ability beyond sex and brain size

NEUROIMAGE. 2017; 155: 234-244 Nº de citas: 18 [doi:10.1016/j.neuroimage.2017.04.029]

Mas, S; Gasso, P; Torra, M; Bioque, M; Lobo, A; Gonzalez-Pinto, A; Olmeda, MS; Corripio, I; Vieta, E; Castro-Fornieles, J; Rodriguez-Jimenez, R; Bobes, J; Usall, J; Llerena, A; Saiz-Ruiz, J; Bernardo, M; Lafuente, A; PEPs Grp.

Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients

EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2017; 27(7): 647-656 Nº de citas: 13 [doi:10.1016/j.euroneuro.2017.03.012]

Bugarski-Kirola, D; Blaettler, T; Arango, C; Fleischhacker, WW; Garibaldi, G; Wang, A; Dixon, M; Bressan, RA; Nasrallah, H; Lawrie, S; Napieralski, J; Ochi-Lohmann, T; Reid, C; Marder, SR.

Bitopertin in Negative Symptoms of Schizophrenia-Results From the Phase III FlashLyte and DayLyte Studies

Biological Psychiatry. 2017; 82(1): 8-16 Nº de citas: 117 [doi:10.1016/j.biopsych.2016.11.014]

Fraguas, D; Diaz-Caneja, CM; Rodriguez-Quiroga, A; Arango, C.

Oxidative Stress and Inflammation in Early Onset First Episode Psychosis: A Systematic Review and Meta-Analysis

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2017; 20(6): 435-444 Nº de citas: 84 [doi:10.1093/ijnp/pyx015]

Roman, FJ; Iturria-Medina, Y; Martinez, K; Karama, S; Burgaleta, M; Evans, AC; Jaeggi, SM; Colom, R.

Enhanced structural connectivity within a brain sub-network supporting working memory and engagement processes after cognitive training

NEUROBIOLOGY OF LEARNING AND MEMORY. 2017; 141: 33-43 Nº de citas: 25 [doi:10.1016/j.nlm.2017.03.010]

de la Serna, E; Sugranyes, G; Sanchez-Gistau, V; Rodriguez-Toscano, E; Baeza, I; Vila, M; Romero, S; Sanchez-Gutierrez, T; Penzol, MJ; Moreno, D; Castro-Fornieles, J.

Neuropsychological characteristics of child and adolescent offspring of patients with schizophrenia or bipolar disorder

Schizophrenia Research. 2017; 183: 110-115 Nº de citas: 25 [doi:10.1016/j.schres.2016.11.007]

Rapado-Castro, M; Dodd, S; Bush, AI; Malhi, GS; Skvarc, DR; On, ZX; Berk, M; Dean, OM.

Cognitive effects of adjunctive N-acetyl cysteine in psychosis

PSYCHOLOGICAL MEDICINE. 2017; 47(5): 866-876 Nº de citas: 90 [doi:10.1017/S0033291716002932]

Montejo, AL; Arango, C; Bernardo, M; Carrasco, JL; Crespo-Facorro, B; Cruz, JJ; Del Pino-Montes, J; Garcia-Escudero, MA; Garcia-Rizo, C; Gonzalez-Pinto, A; Hernandez, AI; Martin-Carrasco, M; Mayoral-Cleries, F; Mayoral-Van Son, J; Mories, MT; Pachiarotti, I; Perez, J; Ros, S; Vieta, E.

Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics

FRONTIERS IN NEUROENDOCRINOLOGY. 2017; 45: 25-34 Nº de citas: 50 [doi:10.1016/j.yfrne.2017.02.003]

Mane, A; Berge, D; Penzol, MJ; Parellada, M; Bioque, M; Lobo, A; Gonzalez-Pinto, A; Corripio, I; Cabrera, B; Sanchez-Torres, AM; Saiz-Ruiz, J; Bernardo, M; PEPs Grp.

Cannabis use, COMT, BDNF and age at first-episode psychosis

PSYCHIATRY RESEARCH. 2017; 250: 38-43 Nº de citas: 24 [doi:10.1016/j.psychres.2017.01.045]